Swiss pharma industry faces historic patent cliff

Hundreds of billions of dollars in annual sales are at risk due to patent expirations in the pharmaceutical industry.

Published 7sem2 sources✓ ConfirmedImportantupdated 6sem
Lire en français
≈ 17s

The fact

Novartis and Roche are particularly affected by this critical period.

Companies must innovate to offset these losses.

2 sources — click a link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Suisse · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 2 media sources · identified on October 2, 2026
← Back to home
Discover

Read more

All monde →